Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 4 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Recs

2
Player Avatar bo4fool (50.69) Submitted: 1/6/2011 12:43:38 PM : Outperform Start Price: $23.06 BRLI Score: -31.69

gene testing and other niche tests coming into demand

Featured Broker Partners


Advertisement